• Hybrid Core-Shell Particles for Systemic mRNA Delivery

  2026-09-21

  Andretto et al. developed hyaluronic-acid-coated liposome–mRNA complexes that preserved particle size and mRNA binding while changing surface charge and biological distribution. The study shows why nanoparticle accumulation and the location of translated protein should be measured separately when designing systemic mRNA delivery systems.

• Amikacin (BAY416651) in Resistance Assays

  2026-09-21

  Amikacin (BAY416651) offers a mechanistically defined way to connect aminoglycoside susceptibility with plasmid-mediated carbapenem resistance. This guide develops a gene-to-phenotype assay framework for Enterobacterales research, with practical handling guidance and evidence-based interpretation.

• Vacuolin-1: Reliable Lysosomal Exocytosis Assays

  2026-09-20

  Learn how Vacuolin-1, SKU C4084, can help laboratories separate lysosomal exocytosis from cell injury in viability, secretion, and membrane-repair experiments. This scenario-driven guide covers assay compatibility, protocol parameters, data interpretation, and practical product-selection criteria using documented product specifications and disease-model evidence.

• BMS 309403: Reliable FABP4 Assays

  2026-09-19

  This scenario-driven guide explains how BMS 309403, SKU B7794, can improve experimental reasoning in viability, inflammation, lipid-accumulation, and foam-cell assays. It connects documented FABP4 potency, formulation, handling, dose selection, and mechanistic evidence with practical laboratory controls.

• GW4064: Reliable FXR Assay Workflows

  2026-09-19

  GW4064 (SKU B1527) is a non-steroidal FXR agonist for investigating bile acid, cholesterol, triglyceride, and fibrosis-related signaling in cell-based assays. This scenario-driven guide addresses solvent handling, viability-assay compatibility, dose interpretation, and practical product-selection criteria.

• Moxidectin–Nystatin Synergy in Oral Candidiasis

  2026-09-18

  The 2024 reference study shows that moxidectin can increase Candida albicans ergosterol biosynthesis, thereby strengthening the activity of the polyenes amphotericin B and Nystatin against fungal growth, biofilms, and oral infection. Transcriptomic, genetic, biochemical, and mouse-model evidence supports ergosterol elevation as the mechanistic basis of this potentiation, while also defining important limits for translation beyond oral candidiasis.

• Caspase-8 Fluorometric Assay Kit Workflow

  2026-09-17

  Build a rapid, quantitative caspase-8 activity workflow for apoptosis, combination-therapy, and programmed cell death studies. This guide translates hyperthermia–cisplatin findings into practical assay controls, optimization steps, and orthogonal validation strategies.

• Annexin V-FITC/PI Apoptosis Assay Kit Guide

  2026-09-17

  The Annexin V-FITC/PI Apoptosis Assay Kit provides a rapid two-parameter method for separating viable, early apoptotic, and membrane-compromised cell populations by flow cytometry or fluorescence microscopy. It is suitable for research-stage cell-death profiling, but it should not be used alone to assign a definitive molecular death mechanism or for diagnostic purposes.

• Norovirus Co-opts NINJ1 for Selective Secretion

  2026-09-16

  Song et al. show that murine norovirus repurposes the membrane-rupture factor NINJ1 to release the viral protein NS1 while also causing broader damage-associated molecular pattern release. Through CRISPR screening, imaging, mutagenesis, and mouse infection studies, the work connects caspase-3-dependent processing with a selective unconventional secretion pathway.

• Thapsigargin: Mapping Calcium-to-ER Stress Causality

  2026-09-16

  Thapsigargin is a powerful SERCA pump inhibitor for dissecting the temporal relationship between calcium signaling, endoplasmic reticulum stress, inflammation, and apoptosis. This article translates mechanistic evidence into a causality-focused assay strategy rather than treating every stress marker as equivalent.

• From Barrier Biology to Faster Genotyping

  2026-09-15

  Mechanistic studies of intestinal barrier protection show why allele-aware, reproducible sample preparation matters in translational research. This thought-leadership guide connects NR1I3–CDH1–E-cadherin biology with practical PCR genotyping workflows and evaluates where a direct-lysis approach can accelerate evidence generation.

• SmD2 Acetylation, Splicing, and PARP Sensitivity in HCC

  2026-09-15

  The reference study identifies SmD2 as an acetylation-regulated spliceosome component that connects alternative splicing, DNA-damage repair, and PARP inhibitor response in hepatocellular carcinoma. Its findings support a combination strategy involving HDAC inhibition and PARP blockade, while also highlighting the need for validation across genetically and clinically diverse HCC models.

• MG-132 (Z-LLL-al) Experimental Workflows

  2026-09-14

  MG-132 (Z-LLL-al) is a cell-permeable proteasome probe for connecting protein turnover with apoptosis, cell-cycle control, and oxidative stress. This practical guide shows how to build reproducible dose–time workflows and use MG-132 to interrogate the HIF-1 and ferroptosis-related observations reported in neuronal cell models.

• BMS 309403 and the SERCA2–FABP4 Atherosclerosis Axis

  2026-09-14

  The SERCA2–calcineurin–FoxO1–FABP4 pathway connects calcium-handling stress with macrophage lipid accumulation and atherosclerosis. This thought-leadership guide translates recent mechanistic evidence into an experimental strategy for using BMS 309403 as a selective FABP4 inhibitor while preserving the distinction between preclinical validation and clinical translation.

• Toremifene vs Tamoxifen in Advanced Breast Cancer

  2026-09-13

  This Cochrane review evaluated whether toremifene offers clinically meaningful advantages over tamoxifen for advanced breast cancer. Its synthesis found no consistent evidence that either agent was superior across tumor response, time to progression, overall survival, or evaluated adverse events, supporting a cautious, evidence-based role for comparative endocrine therapy research.

7994 records 1/533 page Next 12345 下5页 Last page